Back

Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockers

27 May 2018 (08:45 - 08:55)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Comorbidities HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT
Professor T. Jaarsma (Linkoping, SE)
Slides Video
Presentation thumbnail
Discussion - HF-Wii
Video
Presentation thumbnail
Discussion - BB-meta-HF
Video
Presentation thumbnail
Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AF
Professor W. Abraham (Columbus, US)
Slides Video
Presentation thumbnail
Discussion - GENETIC-AF
Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2018

27 May 2018 08:45 CET
You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Prevalence of obesity and its association with cardiometablic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
1 July 2021
thumbnail
Congress Presentation
Galectin-4 is associated with diabetes in a heart failure population
22 May 2023
thumbnail
Congress Presentation
The importance of diabetes mellitus in cardiac resynchronization therapy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources